Pay well, but work hard - Recensione dipendente - Finance Director presso Merck

4,0
23 feb 2023
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Advancement opportunities have been plentiful. Great people. Finance is viewed as a business partner.

Svantaggi

Finance has a lot of inefficiencies and as a result has to work really hard to get basic FP&A questions answered.

Esplora altre recensioni su Merck

5,0
29 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Benefits and pay are great

Svantaggi

Depends on manager and organization is how your experience and work life balance will be

4,0
30 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Svantaggi

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Vedi recensioni per: Utile|Valutazione|Data|Tutto